Clarithromycin-induced rhabdomyolysis: A case report

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 283-285

  Pasqualetti, Giuseppe ^a   Bini, Giacomo ^a   Tognini, Sara ^a   Polini, Antonio ^a   Monzani, Fabio ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Clarithromycin; Pneumonia; Rhabdomyolysis

Indexed keywords

BISOPROLOL; CEFTRIAXONE; CLARITHROMYCIN; CREATINE; CREATINE KINASE; DALTEPARIN; METHYLPREDNISOLONE; MYOGLOBIN; OXITROPIUM BROMIDE; OXYGEN; SALBUTAMOL;

AGED; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; CRYSTALLOID; DRUG WITHDRAWAL; DYSPNEA; FLUID THERAPY; HUMAN; HUMAN CELL; MALE; OXYGEN THERAPY; PNEUMONIA; RESPIRATORY FAILURE; RHABDOMYOLYSIS; SINUS TACHYCARDIA; THORAX RADIOGRAPHY; URINE COLOR;

EID: 84871882237     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S29845     Document Type: Article

References (13)

1. Cunningham G, Dodd TR, Grant DJ, Murdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing. 1997; 26(5):375-382.
2. Mannesse CK, Derkx FH, de Ridder MA, Manint Veld AJ, van der Cammen TJ. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. Br Med J. 1997; 315(7115):1057-1058.
3. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289(13):1652-1658.
4. Tangiisuran B, Wright J, Van der Cammen T, Rajkumar C. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing. 2009;38(4):358-359.
5. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009; 67(9):272-283.
6. Molden E, Andersson KS, Jacobsen D. Interactions between statins and macrolide antibiotics. [Article in Norwegian]. Tidsskr Nor Laegeforen. 2007;127(12):1660-1661.
7. Molden E, Skovlund E, Braathen P. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors. Drug Saf. 2008; 31(7):587-596.
8. Strandell J, Bate A, Hägg S, Edwards IR. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. Br J Clin Pharmacol. 2009;68(3):427-434.
9. Wagner J, Suessmair C, Pfister HW. Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin. J Neurol. 2009; 256(7):1182-1183.
10. Brener ZZ, Bilik I, Khorets B, Winchester JF, Bergman M. Rhabdomyolysis following clarithromycin monotherapy. Am J Med Sci. 2009;338(1):78.
11. Borchard U. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance. Clin Physiol Biochem. 1990;8 Suppl 2:28-34.
12. Balant L, Dayer P, Auckenthaler R. Clinical pharmacokinetics of the third generation cephalosporins. Clin Pharmacokinet. 1985;10(2): 101-143.
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-245.